Breast Cancer Clinical Trials in Baltimore

Showing 301-320 of 805 trials

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203

This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative breast cancer. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving carboplatin with atezolizumab may work better in treating patients with stage IV triple negative breast cancer

Triple Negative Breast CancerStage IV Breast CancerHER2 Negative+1 more

Vanderbilt-Ingram Cancer Center106 participantsStarted Aug 2017

Washington D.C., District of Columbia, United States • Indianapolis, Indiana, United States • Baltimore, Maryland, United States +3 more locations

COMPLETEDNA36 miles

mHealth for Breast Cancer Survivors With Insomnia

NCT05233800

The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.

Breast Cancer SurvivorInsomnia

Medstar Health Research Institute76 participantsStarted Apr 2022

Washington D.C., District of Columbia, United States

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

mHealth for Breast Cancer Survivors With Insomnia

Breast Cancer Trials in Other Cities

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Comprehensive Outcomes for After Cancer Health

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

FPA150 in Patients With Advanced Solid Tumors

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer

Other Conditions in Baltimore